| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.688 | 0.002 | 0.688 | NMDA 2B receptor antagonist | 0.639 0.003 CID_2734 | ||
| 0.689 | 0.004 | 0.689 | Glutamate receptor antagonist | 0.59 0.004 CID_2734 | ||
| 0.641 | 0.02 | 0.641 | Analgesic | 0.504 0.048 CID_2734 | ||
| 0.62 | 0.004 | 0.631 | NMDA receptor antagonist | 0.631 0.004 CID_2734 | CID_2734 | |
| 0.575 | 0.015 | 0.575 | 5 Hydroxytryptamine release inhibitor | 0.504 0.031 CID_2734 | ||
| 0.473 | 0.004 | 0.492 | NMDA 2 receptor antagonist | 0.492 0.004 CID_2734 | CID_2734 | |
| 0.481 | 0.031 | 0.481 | GABA C receptor rho-3 antagonist | 0.467 0.036 CID_2734 | ||
| 0.406 | 0.004 | 0.406 | ATPase inhibitor | 0.333 0.005 CID_2734 | ||
| 0.402 | 0.009 | 0.514 | Amylase inhibitor | 0.514 0.005 CID_2734 | CID_2734 | |
| 0.381 | 0.004 | 0.381 | Autotaxin inhibitor | 0.265 0.005 CID_2734 | ||
| 0.471 | 0.1 | 0.491 | Antiinflammatory | 0.491 0.091 CID_2734 | CID_2734 | |
| 0.368 | 0.004 | 0.393 | Dopamine D2 agonist | 0.393 0.004 CID_2734 | CID_2734 | |
| 0.42 | 0.065 | 0.42 | Histamine release inhibitor | 0.395 0.079 CID_2734 | ||
| 0.396 | 0.048 | 0.418 | Aldehyde oxidase inhibitor | 0.418 0.044 CID_2734 | CID_2734 | |
| 0.377 | 0.043 | 0.427 | Lipoxygenase inhibitor | 0.427 0.031 CID_2734 | CID_2734 | |
| 0.327 | 0.009 | 0.327 | Alkaline phosphatase inhibitor | 0.318 0.01 CID_2734 | ||
| 0.32 | 0.004 | 0.357 | NMDA 2C receptor antagonist | 0.357 0.004 CID_2734 | CID_2734 | |
| 0.324 | 0.027 | 0.387 | RNA-directed DNA polymerase inhibitor | 0.387 0.019 CID_2734 | CID_2734 | |
| 0.304 | 0.017 | 0.304 | Cyclooxygenase inhibitor | 0.279 0.021 CID_2734 | ||
| 0.36 | 0.081 | 0.36 | Calpain 2 inhibitor | 0.223 0.169 CID_2734 | ||
| 0.284 | 0.007 | 0.284 | Nav1.6 sodium channel blocker | 0.204 0.018 CID_2734 | ||
| 0.271 | 0.004 | 0.271 | Mineralocorticoid receptor antagonist | 0.148 0.005 CID_2734 | ||
| 0.283 | 0.025 | 0.283 | Diuretic | 0.282 0.026 CID_2734 | ||
| 0.295 | 0.042 | 0.295 | Anticonvulsant | |||
| 0.255 | 0.002 | 0.255 | Kynurenine 3 monooxygenase inhibitor | 0.216 0.002 CID_2734 | ||
| 0.297 | 0.046 | 0.334 | 5 Hydroxytryptamine uptake stimulant | 0.334 0.031 CID_2734 | CID_2734 | |
| 0.258 | 0.007 | 0.258 | HIV-1 reverse transcriptase inhibitor | 0.213 0.009 CID_2734 | ||
| 0.257 | 0.013 | 0.257 | 5 Hydroxytryptamine 3E antagonist | 0.18 0.107 CID_2734 | ||
| 0.262 | 0.02 | 0.262 | Hemostatic | 0.235 0.024 CID_2734 | ||
| 0.246 | 0.005 | 0.44 | Macrophage migration inhibitory factor inhibitor | 0.44 0.003 CID_2734 | CID_2734 | |
| 0.306 | 0.068 | 0.306 | 5 Hydroxytryptamine release stimulant | 0.164 0.16 CID_2734 | ||
| 0.239 | 0.007 | 0.255 | Dopamine agonist | 0.255 0.007 CID_2734 | CID_2734 | |
| 0.272 | 0.044 | 0.272 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.194 0.081 CID_2734 | ||
| 0.249 | 0.025 | 0.249 | Antipruritic | 0.208 0.044 CID_2734 | ||
| 0.241 | 0.021 | 0.241 | Insulin secretagoues | 0.202 0.035 CID_2734 | ||
| 0.292 | 0.073 | 0.292 | Spasmolytic | 0.279 0.079 CID_2734 | ||
| 0.224 | 0.01 | 0.224 | Potassium channel (Ca-activated) activator | 0.186 0.018 CID_2734 | ||
| 0.214 | 0.007 | 0.214 | Inducible nitric-oxide synthase inhibitor | 0.136 0.02 CID_2734 | ||
| 0.249 | 0.045 | 0.249 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.145 0.092 CID_2734 | ||
| 0.204 | 0.006 | 0.204 | Potassium channel large-conductance Ca-activated activator | 0.156 0.01 CID_2734 | ||
| 0.314 | 0.125 | 0.407 | Antibacterial | 0.407 0.074 CID_2734 | CID_2734 | |
| 0.222 | 0.034 | 0.249 | Succinate dehydrogenase inhibitor | 0.249 0.023 CID_2734 | CID_2734 | |
| 0.259 | 0.076 | 0.259 | Cardiotonic | 0.172 0.149 CID_2734 | ||
| 0.234 | 0.053 | 0.234 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.164 0.107 CID_2734 | ||
| 0.182 | 0.005 | 0.254 | NMDA receptor subunit 3B antagonist | 0.254 0.004 CID_2734 | CID_2734 | |
| 0.226 | 0.054 | 0.226 | Neurotrophic factor enhancer | 0.182 0.095 CID_2734 | ||
| 0.278 | 0.107 | 0.278 | Vasodilator, coronary | 0.247 0.138 CID_2734 | ||
| 0.211 | 0.046 | 0.211 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.175 | 0.012 | 0.175 | Electrolyte absorption antagonist | 0.116 0.039 CID_2734 | ||
| 0.169 | 0.016 | 0.169 | Nitric-oxide synthase inhibitor | 0.104 0.054 CID_2734 | ||
| 0.168 | 0.016 | 0.168 | Phosphodiesterase 7B inhibitor | 0.095 0.063 CID_2734 | ||
| 0.326 | 0.179 | 0.326 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.149 | 0.005 | 0.149 | 5 Hydroxytryptamine 2A agonist | 0.102 0.014 CID_2734 | ||
| 0.228 | 0.085 | 0.278 | DNA synthesis inhibitor | 0.278 0.052 CID_2734 | CID_2734 | |
| 0.157 | 0.016 | 0.157 | Acetylcholine M3 receptor agonist | 0.094 0.049 CID_2734 | ||
| 0.179 | 0.038 | 0.179 | Sodium channel (voltage-gated) blocker | |||
| 0.148 | 0.007 | 0.148 | NMDA 2A receptor antagonist | 0.097 0.014 CID_2734 | ||
| 0.211 | 0.072 | 0.236 | Nitric-oxide synthase stimulant | 0.236 0.043 CID_2734 | CID_2734 | |
| 0.144 | 0.007 | 0.144 | Kallikrein 1 inhibitor | 0.098 0.013 CID_2734 | ||
| 0.162 | 0.03 | 0.162 | GABA receptor agonist | |||
| 0.25 | 0.118 | 0.25 | Thyroid hormone beta antagonist | 0.198 0.156 CID_2734 | ||
| 0.132 | 0.004 | 0.132 | Factor XIa inhibitor | 0.082 0.008 CID_2734 | ||
| 0.161 | 0.034 | 0.161 | Alpha 2b adrenoreceptor antagonist | 0.11 0.066 CID_2734 | ||
| 0.143 | 0.017 | 0.143 | MAP-kinase-activated kinase inhibitor | 0.095 0.044 CID_2734 | ||
| 0.248 | 0.125 | 0.248 | Thyroid hormone antagonist | 0.208 0.155 CID_2734 | ||
| 0.136 | 0.015 | 0.136 | MAP-kinase-activated kinase 2 inhibitor | 0.085 0.039 CID_2734 | ||
| 0.148 | 0.027 | 0.148 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.095 0.06 CID_2734 | ||
| 0.169 | 0.052 | 0.169 | GABA C receptor rho-2 antagonist | 0.163 0.057 CID_2734 | ||
| 0.143 | 0.026 | 0.143 | DNA directed RNA polymerase inhibitor | 0.107 0.049 CID_2734 | ||
| 0.123 | 0.006 | 0.158 | NMDA receptor subunit 3A antagonist | 0.158 0.005 CID_2734 | CID_2734 | |
| 0.22 | 0.104 | 0.253 | Tyrosine 3 hydroxylase inhibitor | 0.253 0.066 CID_2734 | CID_2734 | |
| 0.124 | 0.009 | 0.124 | Acetylcholine M5 receptor agonist | |||
| 0.131 | 0.017 | 0.131 | Bromodomain-containing protein 2 inhibitor | |||
| 0.122 | 0.008 | 0.122 | NMDA receptor glycine site agonist | 0.082 0.027 CID_2734 | ||
| 0.255 | 0.141 | 0.255 | Calcium channel activator | 0.212 0.196 CID_2734 | ||
| 0.122 | 0.01 | 0.122 | Alpha 2 adrenoreceptor agonist | 0.074 0.028 CID_2734 | ||
| 0.118 | 0.007 | 0.118 | Phospholipase D inhibitor | 0.092 0.02 CID_2734 | ||
| 0.132 | 0.025 | 0.132 | 5 Hydroxytryptamine agonist | |||
| 0.129 | 0.022 | 0.129 | Protein kinase B gamma inhibitor | |||
| 0.144 | 0.039 | 0.144 | 5 Hydroxytryptamine 3A agonist | |||
| 0.128 | 0.025 | 0.158 | NADH dehydrogenase inhibitor | 0.158 0.016 CID_2734 | CID_2734 | |
| 0.167 | 0.069 | 0.169 | Arachidonic acid antagonist | 0.169 0.066 CID_2734 | CID_2734 | |
| 0.111 | 0.016 | 0.111 | NMDA receptor agonist | 0.068 0.038 CID_2734 | ||
| 0.21 | 0.119 | 0.21 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.095 | 0.004 | 0.095 | Factor XI inhibitor | 0.048 0.011 CID_2734 | ||
| 0.132 | 0.042 | 0.148 | GABA C receptor agonist | 0.148 0.035 CID_2734 | CID_2734 | |
| 0.12 | 0.032 | 0.12 | Potassium channel activator | |||
| 0.102 | 0.015 | 0.102 | GABA receptor antagonist | 0.052 0.042 CID_2734 | ||
| 0.096 | 0.01 | 0.096 | 5 Hydroxytryptamine 2 agonist | 0.056 0.031 CID_2734 | ||
| 0.118 | 0.032 | 0.13 | Dopamine antagonist | 0.13 0.029 CID_2734 | CID_2734 | |
| 0.168 | 0.082 | 0.168 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | |||
| 0.191 | 0.107 | 0.191 | Aryl hydrocarbon receptor agonist | |||
| 0.089 | 0.005 | 0.089 | Fructose-1,6-bisphosphatase inhibitor | 0.058 0.018 CID_2734 | ||
| 0.12 | 0.037 | 0.12 | Acetylcholine agonist | |||
| 0.148 | 0.066 | 0.148 | Adenylate cyclase stimulant | 0.148 0.065 CID_2734 | ||
| 0.103 | 0.021 | 0.103 | Phosphodiesterase III inhibitor | 0.092 0.027 CID_2734 | ||
| 0.105 | 0.024 | 0.111 | D-Ala-D-Ala ligase inhibitor | 0.111 0.019 CID_2734 | CID_2734 | |
| 0.093 | 0.013 | 0.093 | Phosphodiesterase 3B inhibitor | 0.067 0.017 CID_2734 | ||
| 0.143 | 0.064 | 0.143 | Ca2+-transporting ATPase inhibitor | 0.142 0.068 CID_2734 | ||
| 0.104 | 0.026 | 0.104 | Alpha adrenoreceptor agonist | |||
| 0.081 | 0.003 | 0.081 | Elastase 2A inhibitor | 0.054 0.005 CID_2734 | ||
| 0.081 | 0.003 | 0.081 | Elastase 2 inhibitor | 0.054 0.005 CID_2734 | ||
| 0.094 | 0.016 | 0.094 | 5 Hydroxytryptamine 1A agonist | |||
| 0.141 | 0.064 | 0.141 | Sodium channel blocker | |||
| 0.085 | 0.01 | 0.085 | Progesterone antagonist | 0.055 0.016 CID_2734 | ||
| 0.112 | 0.038 | 0.16 | Androgen antagonist | 0.16 0.02 CID_2734 | CID_2734 | |
| 0.105 | 0.031 | 0.11 | Dopamine D2 antagonist | 0.11 0.03 CID_2734 | CID_2734 | |
| 0.142 | 0.07 | 0.142 | Pregnane X receptor agonist | |||
| 0.093 | 0.022 | 0.093 | 5 Hydroxytryptamine 1 agonist | |||
| 0.096 | 0.025 | 0.096 | Nav1.7 sodium channel blocker | |||
| 0.283 | 0.213 | 0.283 | Caspase 9 stimulant | 0.275 0.223 CID_2734 | ||
| 0.17 | 0.1 | 0.17 | Psychostimulant | |||
| 0.079 | 0.008 | 0.079 | Factor VII inhibitor | 0.047 0.012 CID_2734 | ||
| 0.125 | 0.056 | 0.125 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.101 | 0.032 | 0.101 | 5 Hydroxytryptamine 1A antagonist | |||
| 0.073 | 0.004 | 0.154 | ATP citrate lysase inhibitor | 0.154 0.003 CID_2734 | CID_2734 | |
| 0.111 | 0.044 | 0.13 | MAP kinase kinase 1 inhibitor | 0.13 0.027 CID_2734 | CID_2734 | |
| 0.071 | 0.005 | 0.071 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.122 | 0.057 | 0.253 | Cystathionine beta-synthase inhibitor | 0.253 0.015 CID_2734 | CID_2734 | |
| 0.095 | 0.031 | 0.096 | CDC25A inhibitor | 0.096 0.03 CID_2734 | CID_2734 | |
| 0.113 | 0.05 | 0.113 | Alpha adrenoreceptor antagonist | |||
| 0.068 | 0.004 | 0.068 | Calcitonin gene-related peptide antagonist | 0.059 0.007 CID_2734 | ||
| 0.084 | 0.02 | 0.084 | GABA A receptor antagonist | |||
| 0.073 | 0.01 | 0.073 | Potassium channel (Inward rectifier) activator | |||
| 0.079 | 0.017 | 0.079 | AMPA receptor antagonist | |||
| 0.077 | 0.016 | 0.077 | Kallikrein inhibitor | |||
| 0.074 | 0.013 | 0.074 | Aldosterone antagonist | |||
| 0.081 | 0.02 | 0.081 | Thromboxane antagonist | |||
| 0.077 | 0.016 | 0.077 | Thromboxane A2 antagonist | 0.046 0.04 CID_2734 | ||
| 0.07 | 0.01 | 0.07 | Potassium channel (ATP-sensitive) activator | |||
| 0.128 | 0.07 | 0.146 | Alpha-N-acetylglucosaminidase inhibitor | 0.146 0.057 CID_2734 | CID_2734 | |
| 0.095 | 0.037 | 0.095 | Glycine receptor antagonist | 0.075 0.066 CID_2734 | ||
| 0.115 | 0.057 | 0.115 | Ferrochelatase inhibitor | 0.095 0.076 CID_2734 | ||
| 0.078 | 0.021 | 0.091 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.091 0.014 CID_2734 | CID_2734 | |
| 0.101 | 0.047 | 0.101 | Alpha 2 adrenoreceptor antagonist | |||
| 0.077 | 0.024 | 0.077 | MDM2 inhibitor | |||
| 0.175 | 0.124 | 0.175 | ErbB-1 antagonist | |||
| 0.117 | 0.066 | 0.117 | 5 Hydroxytryptamine antagonist | |||
| 0.106 | 0.055 | 0.154 | UDP-glucose 4-epimerase inhibitor | 0.154 0.027 CID_2734 | CID_2734 | |
| 0.078 | 0.028 | 0.078 | Aryl hydrocarbon receptor antagonist | |||
| 0.09 | 0.041 | 0.09 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.055 | 0.006 | 0.055 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.055 | 0.006 | 0.055 | Carnitine palmitoyltransferase inhibitor | |||
| 0.182 | 0.133 | 0.182 | Calpain inhibitor | |||
| 0.092 | 0.043 | 0.092 | Glutamate receptor agonist | |||
| 0.138 | 0.091 | 0.138 | Anticoagulant | |||
| 0.061 | 0.014 | 0.061 | Purinergic P2X4 antagonist | 0.045 0.032 CID_2734 | ||
| 0.091 | 0.045 | 0.091 | Acetylcholine nicotinic agonist | |||
| 0.163 | 0.117 | 0.163 | HERG channel blocker | |||
| 0.06 | 0.014 | 0.06 | Dopamine D3 agonist | 0.06 0.014 CID_2734 | ||
| 0.124 | 0.078 | 0.124 | NADPH oxidase inhibitor | 0.124 0.078 CID_2734 | ||
| 0.094 | 0.049 | 0.094 | Interleukin 5 antagonist | |||
| 0.107 | 0.062 | 0.12 | DOPA decarboxylase inhibitor | 0.12 0.045 CID_2734 | CID_2734 | |
| 0.065 | 0.02 | 0.065 | Acetylcholine M1 receptor agonist | |||
| 0.12 | 0.075 | 0.12 | Cathepsin H inhibitor | |||
| 0.069 | 0.024 | 0.069 | Prostaglandin E2 antagonist | |||
| 0.071 | 0.027 | 0.071 | Acetylcholine muscarinic agonist | |||
| 0.061 | 0.017 | 0.061 | Adenylate cyclase 1 inhibitor | |||
| 0.082 | 0.038 | 0.082 | GABA B receptor agonist | 0.077 0.05 CID_2734 | ||
| 0.077 | 0.035 | 0.147 | Dopamine D1 antagonist | 0.147 0.015 CID_2734 | CID_2734 | |
| 0.074 | 0.032 | 0.074 | Glutamate (mGluR6) antagonist | 0.063 0.056 CID_2734 | ||
| 0.089 | 0.049 | 0.089 | GABA A receptor agonist | |||
| 0.067 | 0.027 | 0.067 | Neuropeptide Y5 antagonist | |||
| 0.098 | 0.058 | 0.098 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.149 | 0.109 | 0.167 | Phospholipase C inhibitor | 0.167 0.077 CID_2734 | CID_2734 | |
| 0.08 | 0.041 | 0.08 | Vanilloid 4 agonist | |||
| 0.092 | 0.054 | 0.092 | Ca(v)2.2 blocker | |||
| 0.054 | 0.016 | 0.054 | GABA B receptor antagonist | |||
| 0.066 | 0.028 | 0.066 | CC chemokine 2 receptor antagonist | |||
| 0.042 | 0.004 | 0.042 | Acid ceramidase inhibitor | 0.024 0.023 CID_2734 | ||
| 0.071 | 0.034 | 0.071 | 5 Hydroxytryptamine 3 agonist | |||
| 0.129 | 0.092 | 0.501 | Peroxidase inhibitor | 0.501 0.009 CID_2734 | CID_2734 | |
| 0.039 | 0.005 | 0.039 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.025 0.014 CID_2734 | ||
| 0.124 | 0.09 | 0.217 | Lipid peroxidase inhibitor | 0.217 0.035 CID_2734 | CID_2734 | |
| 0.075 | 0.042 | 0.08 | Peroxisome proliferator-activated receptor gamma antagonist | 0.08 0.034 CID_2734 | CID_2734 | |
| 0.071 | 0.038 | 0.071 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.107 | 0.073 | 0.107 | Nav1.5 sodium channel blocker | |||
| 0.046 | 0.013 | 0.046 | Acetylcholine M4 receptor agonist | |||
| 0.066 | 0.035 | 0.066 | Plasminogen activator inhibitor | |||
| 0.084 | 0.053 | 0.107 | Adrenaline agonist | 0.107 0.032 CID_2734 | CID_2734 | |
| 0.063 | 0.033 | 0.063 | Nicotinic neuronal receptor agonist | |||
| 0.064 | 0.034 | 0.074 | Beta 2 adrenoreceptor agonist | 0.074 0.014 CID_2734 | CID_2734 | |
| 0.107 | 0.077 | 0.107 | TRPA1 agonist | |||
| 0.049 | 0.02 | 0.049 | Factor VIIa inhibitor | |||
| 0.096 | 0.067 | 0.096 | Glutamate (mGluR7) agonist | |||
| 0.052 | 0.023 | 0.052 | Benzodiazepine antagonist | |||
| 0.042 | 0.014 | 0.042 | Potassium channel small-conductance Ca-activated activator | |||
| 0.094 | 0.066 | 0.094 | Sphingomyelinase inhibitor | |||
| 0.121 | 0.095 | 0.121 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.127 | 0.102 | 0.127 | Thiol protease inhibitor | |||
| 0.053 | 0.028 | 0.053 | Glutamate (mGluR group I) agonist | |||
| 0.047 | 0.022 | 0.047 | Alpha 1L adrenoreceptor agonist | |||
| 0.06 | 0.036 | 0.06 | Alpha 1 adrenoreceptor agonist | |||
| 0.2 | 0.177 | 0.2 | Antithrombotic | |||
| 0.037 | 0.015 | 0.037 | Cholesterol ester transfer protein antagonist | |||
| 0.071 | 0.05 | 0.071 | Benzodiazepine agonist | |||
| 0.112 | 0.091 | 0.142 | Glycogen synthase kinase-3 alpha inhibitor | 0.142 0.072 CID_2734 | CID_2734 | |
| 0.028 | 0.008 | 0.028 | Imidazoline I1 receptor antagonist | |||
| 0.05 | 0.029 | 0.05 | Glutamate (mGluR5) antagonist | |||
| 0.088 | 0.067 | 0.088 | Glutamate release inhibitor | |||
| 0.093 | 0.073 | 0.095 | GABA C receptor rho-1 antagonist | 0.095 0.07 CID_2734 | CID_2734 | |
| 0.072 | 0.052 | 0.074 | Lipase inhibitor | 0.074 0.05 CID_2734 | CID_2734 | |
| 0.151 | 0.132 | 0.159 | Insulin sensitizer | 0.159 0.12 CID_2734 | CID_2734 | |
| 0.061 | 0.042 | 0.061 | Purinergic P2X1 antagonist | 0.06 0.043 CID_2734 | ||
| 0.099 | 0.08 | 0.116 | GABA C receptor antagonist | 0.116 0.056 CID_2734 | CID_2734 | |
| 0.069 | 0.05 | 0.069 | Prostaglandin-E synthase inhibitor | |||
| 0.082 | 0.064 | 0.082 | Histamine N-methyltransferase inhibitor | |||
| 0.033 | 0.014 | 0.033 | Carnitine palmitoyltransferase 1A inhibitor | |||
| 0.038 | 0.02 | 0.038 | Plasma kallikrein inhibitor | |||
| 0.054 | 0.037 | 0.054 | Nicotinic alpha7 receptor agonist | |||
| 0.06 | 0.043 | 0.066 | Carbamoyl phosphate synthetase inhibitor | 0.066 0.038 CID_2734 | CID_2734 | |
| 0.047 | 0.03 | 0.047 | Glutamate (mGluR5) agonist | |||
| 0.089 | 0.073 | 0.139 | Creatine kinase inhibitor | 0.139 0.029 CID_2734 | CID_2734 | |
| 0.094 | 0.077 | 0.094 | Mediator release inhibitor | 0.087 0.085 CID_2734 | ||
| 0.098 | 0.081 | 0.098 | Protein kinase C gamma inhibitor | |||
| 0.034 | 0.018 | 0.034 | Prostaglandin EP3 antagonist | |||
| 0.069 | 0.054 | 0.069 | Epoxide hydrolase inhibitor | |||
| 0.049 | 0.034 | 0.049 | Bromodomain-containing protein 3 inhibitor | |||
| 0.058 | 0.043 | 0.077 | Androgen agonist | 0.077 0.025 CID_2734 | CID_2734 | |
| 0.071 | 0.056 | 0.071 | Alpha 2a adrenoreceptor antagonist | |||
| 0.056 | 0.042 | 0.056 | Dopamine uptake inhibitor | |||
| 0.102 | 0.088 | 0.109 | Microtubule formation inhibitor | 0.109 0.075 CID_2734 | CID_2734 | |
| 0.109 | 0.096 | 0.109 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.055 | 0.042 | 0.055 | 5 Hydroxytryptamine 7 agonist | |||
| 0.107 | 0.094 | 0.107 | Cyclooxygenase 3 inhibitor | |||
| 0.055 | 0.043 | 0.062 | Pregnane X receptor antagonist | 0.062 0.027 CID_2734 | CID_2734 | |
| 0.041 | 0.029 | 0.057 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.057 0.009 CID_2734 | CID_2734 | |
| 0.066 | 0.054 | 0.066 | Glutamate (mGluR group I) antagonist | |||
| 0.019 | 0.009 | 0.019 | Calcitonin gene-related peptide 1 receptor antagonist | |||
| 0.039 | 0.029 | 0.042 | CF transmembrane conductance regulator antagonist | 0.042 0.021 CID_2734 | CID_2734 | |
| 0.02 | 0.011 | 0.02 | Progesterone agonist | |||
| 0.038 | 0.03 | 0.045 | Dopamine D5 agonist | 0.045 0.022 CID_2734 | CID_2734 | |
| 0.134 | 0.126 | 0.134 | Platelet adhesion inhibitor | 0.132 0.129 CID_2734 | ||
| 0.065 | 0.057 | 0.065 | Exportin-1 inhibitor | |||
| 0.089 | 0.081 | 0.089 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.045 | 0.038 | 0.045 | Carnitine palmitoyltransferase 1B inhibitor | |||
| 0.036 | 0.029 | 0.036 | TRPM8 blocker | |||
| 0.082 | 0.075 | 0.084 | HIV-1 integrase (Overall Integration) inhibitor | 0.084 0.072 CID_2734 | CID_2734 | |
| 0.042 | 0.035 | 0.042 | Histamine H1 receptor agonist | |||
| 0.05 | 0.043 | 0.05 | Acetylcholine M2 receptor agonist | |||
| 0.081 | 0.074 | 0.083 | Triose-phosphate isomerase inhibitor | 0.083 0.07 CID_2734 | CID_2734 | |
| 0.025 | 0.019 | 0.025 | Sodium/glucose cotransporter inhibitor | |||
| 0.026 | 0.02 | 0.026 | Integrin alpha2beta1 antagonist | |||
| 0.052 | 0.046 | 0.052 | Dihydroorotate oxidase inhibitor | |||
| 0.061 | 0.057 | 0.061 | Alpha 1a adrenoreceptor antagonist | |||
| 0.014 | 0.01 | 0.014 | Glucagon agonist | |||
| 0.051 | 0.048 | 0.051 | Dopamine D4 antagonist | |||
| 0.034 | 0.031 | 0.034 | Integrin alpha2 antagonist | |||
| 0.035 | 0.033 | 0.035 | Vascular adhesion protein 1 inhibitor | |||
| 0.065 | 0.063 | 0.065 | Alpha 1 adrenoreceptor antagonist | |||
| 0.144 | 0.142 | 0.144 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.068 | 0.066 | 0.068 | GABA aminotransferase inhibitor | |||
| 0.051 | 0.051 | 0.086 | Raf kinase C inhibitor | 0.086 0.03 CID_2734 | CID_2734 | |
| 0.064 | 0.063 | 0.064 | Vanilloid antagonist | |||
| 0.041 | 0.054 | 0.046 | Beta adrenoreceptor agonist | 0.046 0.028 CID_2734 | CID_2734 | |
| 0.02 | 0.035 | 0.031 | Thyroid hormone agonist | 0.031 0.011 CID_2734 | CID_2734 | |
| 0.178 | 0.194 | 0.212 | Insulysin inhibitor | 0.212 0.14 CID_2734 | CID_2734 | |
| 0.1 | 0.118 | 0.193 | Interleukin 4 antagonist | 0.193 0.024 CID_2734 | CID_2734 | |
| 0.024 | 0.044 | 0.04 | Phosphoglycerate kinase inhibitor | 0.04 0.02 CID_2734 | CID_2734 | |
| 0.106 | 0.129 | 0.123 | Mannose-6-phosphate isomerase inhibitor | 0.123 0.096 CID_2734 | CID_2734 | |
| 0.027 | 0.05 | 0.046 | Urate transporter 1 inhibitor | 0.046 0.021 CID_2734 | CID_2734 | |
| 0.038 | 0.063 | 0.064 | Aromatase inhibitor | 0.064 0.038 CID_2734 | CID_2734 | |
| 0.064 | 0.088 | 0.104 | Estrogen receptor alpha antagonist | 0.104 0.025 CID_2734 | CID_2734 | |
| 0.047 | 0.082 | 0.062 | Beta adrenoreceptor antagonist | 0.062 0.052 CID_2734 | CID_2734 | |
| 0.048 | 0.083 | 0.115 | Histidine decarboxylase inhibitor | 0.115 0.027 CID_2734 | CID_2734 | |
| 0.151 | 0.186 | 0.17 | Superoxide dismutase inhibitor | 0.17 0.156 CID_2734 | CID_2734 | |
| 0.067 | 0.106 | 0.102 | Urease inhibitor | 0.102 0.065 CID_2734 | CID_2734 | |
| 0.018 | 0.062 | 0.038 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.038 0.017 CID_2734 | CID_2734 | |
| 0.079 | 0.127 | 0.101 | MAP kinase kinase inhibitor | 0.101 0.094 CID_2734 | CID_2734 | |
| 0.071 | 0.121 | 0.091 | Xanthine oxidase inhibitor | 0.091 0.07 CID_2734 | CID_2734 | |
| 0.189 | 0.292 | 0.24 | Cyclophilin D inhibitor | 0.24 0.225 CID_2734 | CID_2734 | |
| 0.101 | 0.205 | 0.143 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.143 0.086 CID_2734 | CID_2734 | |
| 0.122 | 0.233 | 0.18 | Prostaglandin dehydrogenase inhibitor | 0.18 0.172 CID_2734 | CID_2734 | |
| 0.034 | 0.155 | 0.059 | Heat shock protein 90 beta antagonist | 0.059 0.042 CID_2734 | CID_2734 | |
| 0.025 | 0.152 | 0.049 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.049 0.044 CID_2734 | CID_2734 | |
| 0.049 | 0.209 | 0.165 | Estrogen receptor beta antagonist | 0.165 0.013 CID_2734 | CID_2734 | |
| 0.042 | 0.223 | 0.089 | Uric acid excretion stimulant | 0.089 0.066 CID_2734 | CID_2734 | |
| 0.065 | 0.277 | 0.135 | Heat shock protein 90 alpha antagonist | 0.135 0.104 CID_2734 | CID_2734 | |
| 0.07 | 0.307 | 0.218 | Free radical scavenger | 0.218 0.084 CID_2734 | CID_2734 | |
| 0.056 | 0.302 | 0.137 | Heat shock protein 90 antagonist | 0.137 0.088 CID_2734 | CID_2734 | |
| 0.013 | 0.271 | 0.033 | Estrogen-related receptor beta antagonist | 0.033 0.022 CID_2734 | CID_2734 | |
| 0.141 | 0.422 | 0.231 | Calcium channel L-type activator | 0.231 0.228 CID_2734 | CID_2734 | |
| 0.041 | 0.354 | 0.155 | Estrogen antagonist | 0.155 0.021 CID_2734 | CID_2734 | |
| 0.052 | 0.41 | 0.219 | Antioxidant | 0.219 0.102 CID_2734 | CID_2734 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |